UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis

Journal of allergy and clinical immunology, 2016-01, Vol.137 (1), p.168-178.e1

2016

Volltextzugriff (PDF)

Management of Anesthesia in Adult and Pediatric Mastocytosis: A Study of the Spanish Network on Mastocytosis (REMA) Based on 726 Anesthetic Procedures

International archives of allergy and immunology, 2015-01, Vol.167 (1), p.47-56

2015

Volltextzugriff (PDF)

Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes [version 1; peer review: 2 approved]

F1000 research, 2016, Vol.5, p.2666-2666

2016

Volltextzugriff (PDF)

Mastocytosis presenting with mast cell‐mediator release‐associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features

Clinical and translational allergy, 2022-03, Vol.12 (3), p.e12132-n/a

2022

Volltextzugriff (PDF)

Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis

International journal of molecular sciences, 2019-01, Vol.20 (3), p.552

2019

Volltextzugriff (PDF)

Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome

PloS one, 2013-10, Vol.8 (10), p.e76116-e76116

2013

Volltextzugriff (PDF)

Mastocytosis in the skin accompanied by pseudo‐Kaposi’s sarcoma

Journal of dermatology, 2021-05, Vol.48 (5), p.657-660

2021

Volltextzugriff (PDF)

Systemic mastocytosis as a risk factor for severe Hymenoptera sting–induced anaphylaxis

Journal of allergy and clinical immunology, 2013-02, Vol.131 (2), p.614-615

2013

Volltextzugriff (PDF)

Venom Immunotherapy in Patients with Clonal Mast Cell Disorders: Efficacy, Safety, and Practical Considerations

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2013-09, Vol.1 (5), p.474-478

2013

Volltextzugriff (PDF)

Bone Marrow Expression of Mast Cell Disorders

Immunology and allergy clinics of North America, 2018-08, Vol.38 (3), p.379

2018

Volltextzugriff (PDF)

Altered innate immune profile in blood of systemic mastocytosis patients

Clinical and translational allergy, 2022-06, Vol.12 (6), p.e12167-n/a

2022

Volltextzugriff (PDF)

Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis

Journal of allergy and clinical immunology, 2013-04, Vol.131 (4), p.1213-1224.e4

2013

Volltextzugriff (PDF)

Systemic mastocytosis presenting as occupational IgE-mediated anaphylaxis to pine processionary caterpillar

Annals of allergy, asthma, & immunology, 2016-09, Vol.117 (3), p.333-334.e1

2016

Volltextzugriff (PDF)

Short-term omalizumab treatment in an adolescent with cutaneous mastocytosis

Annals of allergy, asthma, & immunology, 2013-11, Vol.111 (5), p.425-426

2013

Volltextzugriff (PDF)

Response to celecoxib in a patient with indolent systemic mastocytosis presenting with intractable diarrhea

Annals of allergy, asthma, & immunology, 2015-11, Vol.115 (5), p.456-457

2015

Volltextzugriff (PDF)

Systemic mastocytosis presenting as IgE-mediated food-induced anaphylaxis: A report of two cases

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2015-05, Vol.3 (3), p.456-458

2015

Volltextzugriff (PDF)

Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology

Journal of allergy and clinical immunology, 2019-03, Vol.143 (3), p.880-893

2019

Volltextzugriff (PDF)

Mast cell activation syndromes and anaphylaxis

Annals of allergy, asthma, & immunology, 2020-02, Vol.124 (2), p.143-145.e1

2020

Volltextzugriff (PDF)

Cutaneous Mastocytosis in Adults and Children: New Classification and Prognostic Factors

Immunology and allergy clinics of North America, 2018-08, Vol.38 (3), p.351

2018

Volltextzugriff (PDF)

Mast cell activation syndromes and anaphylaxis: Multiple diseases part of the same spectrum

Annals of allergy, asthma, & immunology, 2020-02, Vol.124 (2), p.143-145.e1

2020

Volltextzugriff (PDF)

Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis

Blood, 2019-08, Vol.134 (5), p.456-468

2019

Volltextzugriff (PDF)

KIT D816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes

Allergy (Copenhagen), 2023-05, Vol.78 (5), p.1347-1359

2023

Volltextzugriff (PDF)

Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature

Oncotarget, 2017-09, Vol.8 (40), p.68950-68963

2017

Volltextzugriff (PDF)

Frequency and prognostic impact of blood-circulating tumor mast cells in mastocytosis

Blood, 2022-01, Vol.139 (4), p.572-583

2022

Volltextzugriff (PDF)

KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes

Allergy (Copenhagen), 2023-05, Vol.78 (5), p.1347-1359

2023

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(51)
Berichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(42)
Humans
(35)
Mastocytosis
(23)
Allergy
(21)
Immunology
(21)
Female
(20)
Adult
(18)
Male
(18)
Mutation
(17)
Proto-Oncogene Proteins C-Kit - Genetics
(14)
Bone Marrow
(13)
Aged
(12)
Allergy And Immunology
(12)
Mastocytosis, Systemic - Diagnosis
(12)
Middle Aged
(12)
Mast Cells
(11)
Adolescent
(9)
Flow Cytometry
(9)
Hematology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis

Management of Anesthesia in Adult and Pediatric Mastocytosis: A Study of the Spanish Network on Mastocytosis (REMA) Based on 726 Anesthetic Procedures

Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes [version 1; peer review: 2 approved]

Mastocytosis presenting with mast cell‐mediator release‐associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features

Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis

Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome

Mastocytosis in the skin accompanied by pseudo‐Kaposi’s sarcoma

Systemic mastocytosis as a risk factor for severe Hymenoptera sting–induced anaphylaxis

Venom Immunotherapy in Patients with Clonal Mast Cell Disorders: Efficacy, Safety, and Practical Considerations

Bone Marrow Expression of Mast Cell Disorders

Altered innate immune profile in blood of systemic mastocytosis patients

Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis

Systemic mastocytosis presenting as occupational IgE-mediated anaphylaxis to pine processionary caterpillar

Short-term omalizumab treatment in an adolescent with cutaneous mastocytosis

Response to celecoxib in a patient with indolent systemic mastocytosis presenting with intractable diarrhea

Systemic mastocytosis presenting as IgE-mediated food-induced anaphylaxis: A report of two cases

Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology

Mast cell activation syndromes and anaphylaxis

Cutaneous Mastocytosis in Adults and Children: New Classification and Prognostic Factors

Mast cell activation syndromes and anaphylaxis: Multiple diseases part of the same spectrum

Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis

KIT D816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes

Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature

Frequency and prognostic impact of blood-circulating tumor mast cells in mastocytosis

KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes

Suchergebnisse filtern